Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viknesvaran Selvarajan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patientsEdwin Sandanaraj, Suman Lal, Viknesvaran Selvarajan, et al.
Frontiers in Cell and Developmental Biology|July 29, 2024
Piloting a scale-up platform for high-quality human T-cells productionViknesvaran Selvarajan, Denise Bei Lin Teo, Chaw-Chiea Chang, et al.
The Journal of Pathology|February 5, 2011
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingSiok-Bian Ng, Viknesvaran Selvarajan, Gaofeng Huang, et al.
Blood|September 17, 2011
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaSiok-Bian Ng, Junli Yan, Gaofeng Huang, et al.
Blood|June 15, 2016
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphomaJunli Yan, Boheng Li, Baohong Lin, et al.
Orphanet Journal of Rare Diseases|December 6, 2014
Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hostsSiok-Bian Ng, Koichi Ohshima, Viknesvaran Selvarajan, et al.
Blood|March 27, 2013
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activityJunli Yan, Siok-Bian Ng, Jim Liang-Seah Tay, et al.
Leukemia & Lymphoma|November 11, 2014
Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotypeSiok-Bian Ng, Koichi Ohshima, Viknesvaran Selvarajan, et al.
Plos One|January 25, 2022
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survivalSanjay de Mel, Nurulhuda Mustafa, Viknesvaran Selvarajan, et al.
Journal for Immunotherapy of Cancer|July 3, 2021
Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaNurulhuda Mustafa, Adina Huey Fang Nee, Jing Yuan Chooi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patientsEdwin Sandanaraj, Suman Lal, Viknesvaran Selvarajan, et al.
Frontiers in Cell and Developmental Biology|July 29, 2024
Piloting a scale-up platform for high-quality human T-cells productionViknesvaran Selvarajan, Denise Bei Lin Teo, Chaw-Chiea Chang, et al.
The Journal of Pathology|February 5, 2011
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingSiok-Bian Ng, Viknesvaran Selvarajan, Gaofeng Huang, et al.
Blood|September 17, 2011
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaSiok-Bian Ng, Junli Yan, Gaofeng Huang, et al.
Blood|June 15, 2016
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphomaJunli Yan, Boheng Li, Baohong Lin, et al.
Orphanet Journal of Rare Diseases|December 6, 2014
Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hostsSiok-Bian Ng, Koichi Ohshima, Viknesvaran Selvarajan, et al.
Blood|March 27, 2013
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activityJunli Yan, Siok-Bian Ng, Jim Liang-Seah Tay, et al.
Leukemia & Lymphoma|November 11, 2014
Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotypeSiok-Bian Ng, Koichi Ohshima, Viknesvaran Selvarajan, et al.
Plos One|January 25, 2022
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survivalSanjay de Mel, Nurulhuda Mustafa, Viknesvaran Selvarajan, et al.
Journal for Immunotherapy of Cancer|July 3, 2021
Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaNurulhuda Mustafa, Adina Huey Fang Nee, Jing Yuan Chooi, et al.
Pageof 2